Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.8 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.8 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |